Article

jdsupra.com on 2020-10-13 21:25

FDA Issues Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic

As the COVID-19 pandemic continues to alter ways of life across the globe, clinical trials must be adapted for participant safety while maintaining ...

Related news

FDA Issues Final Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
Updated FDA COVID-19 Guidance for Conduct of Clinical Trials jdsupra.com
California , United States , Switzerland
The ABCs of DCTs: New FDA Guidance Provides Recommendations for the Conduct of Decentralized Clinical Trials jdsupra.com
FDA Issues Additional Guidance on the Conduct of Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Draft Guidance for Obtaining Postmarket Data on Underrepresented Populations in Drug Clinical Trials jdsupra.com
United States
COVID-19’s impact on clinical trials prompts FDA to issue guidance to assist with study conduct jdsupra.com
California , United States , Switzerland , Phase 1 , Deputy Commissioner
Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic: Guidance for Industry, Investigators, and Institutional Review Boards jdsupra.com
California , United States , Switzerland
FDA Issues Guidance on Clinical Trials During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Allow Sponsors to Modify the Conduct of Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
Conduct of Clinical Trials During the COVID-19 Pandemic: Recommendations from FDA jdsupra.com
California , United States , Switzerland
FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials jdsupra.com
FDA details recommendations for live case presentations during medical device clinical trials in final guidance jdsupra.com
California , United States , Switzerland
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Guidance on Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Guidance on Conducting Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Draft Guidance Regarding Inclusion of Pregnant Women in Clinical Trials jdsupra.com
California , United States , Switzerland
FDA Updates its Guidance on Conducting Clinical Trials During COVID-19 Public Health Emergency jdsupra.com
California , United States , Switzerland
FDA Guidance on Diversity Plans in Clinical Trials: What You Need to Know jdsupra.com
United States , United Kingdom
FDA Issues Draft Guidance on Use of Electronic Informed Consent in Clinical Trials jdsupra.com
FDA Issues Draft Guidance on Digital Health Technologies in Clinical Trials jdsupra.com